Triple-negative breast cancer in young aged Indian women - An overview

The incidence of breast cancer has overtaken cervical cancer over the past decade and becoming the most common type of cancer among Indian women. Morbidity and mortality associated with the type of cancer are disproportionately higher in Indian women. Despite efforts being made to increase awareness about the causes, a large population of Indian women are already present with advanced stages of the disease. Reproductive factors are among the most well-established risk factors for breast cancer. However, their associations with different breast cancer subtypes defined by joint estrogen receptor/progesterone receptor/human epidermal growth factor status remain unclear. Triple-negative breast cancers (TNBCs) are known for early age at presentation, large tumor sizes, and overall poor prognosis. However, Indian studies are scarce with limited follow-up data. Hence, the present study is aimed at characterizing nonmetastatic TNBC patients in our population and comparing their outcomes with the non-TNBC subset. TNBCs are a subset of tumors with poorly understood tumor biology and behavior. Despite being labeled as having aggressive tumor biology and behavior, not many differences are seen in their clinical outcomes when they present as locally advanced cases.

[1]  F. Bray,et al.  Cancer incidence in northern Thailand: Results from six population‐based cancer registries 1993–2012 , 2018, International journal of cancer.

[2]  Recinda L. Sherman,et al.  Annual Report to the Nation on the Status of Cancer, 1975–2014, Featuring Survival , 2017, Journal of the National Cancer Institute.

[3]  A. Mathew,et al.  Prevalence of Triple-Negative Breast Cancer in India: Systematic Review and Meta-Analysis , 2016, Journal of global oncology.

[4]  J. Pietenpol,et al.  Subtyping of triple‐negative breast cancer: Implications for therapy , 2015, Cancer.

[5]  B. Mohanti,et al.  Triple-negative breast cancer: An institutional analysis. , 2014, Indian journal of cancer.

[6]  S. C. Chen,et al.  Distant metastasis in triple-negative breast cancer. , 2013, Neoplasma.

[7]  R. Badwe,et al.  Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India. , 2011, Indian journal of cancer.

[8]  Msolly Awatef,et al.  Breastfeeding reduces breast cancer risk: a case–control study in Tunisia , 2010, Cancer Causes & Control.

[9]  Paolo Boffetta,et al.  Breastfeeding and breast cancer risk in India: A multicenter case‐control study , 2009, International journal of cancer.

[10]  Jeff Myers,et al.  Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design. , 2009, Clinical breast cancer.

[11]  J. Weidhaas,et al.  Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  R. Theriault,et al.  Breast carcinoma in pregnant women , 2003, Cancer.

[13]  J. Nesland,et al.  Pregnancy and breast cancer: a population-based study , 2003, Virchows Archiv.

[14]  K. Hess,et al.  Effect of pregnancy on prognosis for young women with breast cancer , 1994, The Lancet.